Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation

M. Lankeit (Mainz, Germany)

Source: International Congress 2018 – PG19 Heart-lung interaction
Session: PG19 Heart-lung interaction
Session type: Postgraduate Course
Number: 214
Disease area: Pulmonary vascular diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Lankeit (Mainz, Germany). Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation. International Congress 2018 – PG19 Heart-lung interaction

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006

Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Paroxysmal atrial fibrillation as a symptom of pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006

Atrial arrhythmias in pulmonary hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


Pulmonary veno-occlusive disease as a consequence of catheter ablation of atrial fibrillation
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001

Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018

Inflammatory pathways in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation
Source: Eur Respir J 2007; 30: Suppl. 51, 707s
Year: 2007

Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 1343-1348
Year: 2011



Right ventricular reverse remodeling after balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology
Year: 2014


Atrial fibrillation is not a predictor of in-hospital mortality in pulmonary embolism
Source: Eur Respir J 2007; 30: Suppl. 51, 80s
Year: 2007

Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Source: Eur Respir J, 55 (6) 2000189; 10.1183/13993003.00189-2020
Year: 2020



Right atrial enlargement and prognosis in the hemodinamically stable pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012


Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016


Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019


Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011


Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2014; 23: 393-395
Year: 2014


Right heart thrombi in pulmonary embolism
Source: Eur Respir J 2016; 48: 1377-1385
Year: 2016